These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8503120)

  • 1. Variations of protein C in uremic hemodialysed patients.
    Nguyen P; Toupance O; Chanard J; Potron G
    Thromb Res; 1993 Mar; 69(6):509-18. PubMed ID: 8503120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD.
    Bertoli SV; di Belgiojoso GB; Trezzi M; Scorza D; Barone MT; Poggio M; Rossi E; Landriani N; Genderini A
    Adv Perit Dial; 1995; 11():127-30. PubMed ID: 8534685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C assays in uremia.
    Sørensen PJ; Knudsen F; Nielsen AH; Dyerberg J
    Thromb Res; 1989 May; 54(4):301-10. PubMed ID: 2763269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hemodialysis on protein C, protein S, and antithrombin III levels.
    Lai KN; Yin JA; Yuen PM; Li PK
    Am J Kidney Dis; 1991 Jan; 17(1):38-42. PubMed ID: 1824735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C and protein S levels in uremic patients before and after dialysis.
    Demicheli M; Contino L; Iberti M; Ortensia A; Finotto E; Lombardi A; Preda L
    Thromb Res; 1992 Dec; 68(6):451-7. PubMed ID: 1341055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Z and natural anticoagulants in children on peritoneal dialysis and hemodialysis.
    Bek K; Ozkaya O; Fişgin T; Aliyazicioğlu Y; Paksu MS; Ozgen T; Albayrak D; Baysal K
    Pediatr Nephrol; 2007 Jun; 22(6):881-6. PubMed ID: 17124603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis.
    Alwakeel J; Gader AM; Hurieb S; al-Momen AK; Mitwalli A; Abu Aisha H
    Int Urol Nephrol; 1996; 28(2):255-61. PubMed ID: 8836799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis with defibrotide: effects on coagulation parameters.
    Filimberti E; Cinotti S; Salvadori M; Amato M; Longo G; Nazzari M; Morfini M
    Int J Artif Organs; 1992 Oct; 15(10):590-4. PubMed ID: 1428206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis.
    Vaziri ND; Shah GM; Winer RL; Gonzales E; Patel B; Alikhani S; Nguyen QX; Yamamoto J
    Thromb Res; 1989 Jan; 53(2):173-80. PubMed ID: 2522249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III in uremia.
    Jørgensen KA; Stoffersen E
    Scand J Urol Nephrol; 1979; 13(3):299-303. PubMed ID: 531528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Lai KN; Yin JA; Yuen PM; Li PK
    Nephron; 1990; 56(3):271-6. PubMed ID: 2150218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hemodialysis on protein C levels.
    Alegre A; Vicente V; Gonzalez R; Alberca I
    Nephron; 1987; 46(4):386-7. PubMed ID: 3658069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets and antithrombin III in uraemia: the acute effect of haemodialysis.
    Knudsen F; Dyerberg J
    Scand J Clin Lab Invest; 1985 Jun; 45(4):341-7. PubMed ID: 3160101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins.
    High KA
    Arch Pathol Lab Med; 1988 Jan; 112(1):28-36. PubMed ID: 2962557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis.
    Vaziri ND; Toohey J; Paule P; Alikhani S; Hung E
    Int J Artif Organs; 1984 Nov; 7(6):323-6. PubMed ID: 6526526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ; Kao RH; Cheng TY; Huang CC; Chang SL; Lee FN
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hemodialysis and long-term erythropoietin treatment on protein C, and on free and total protein S.
    Clyne N; Egberg N; Lins LE
    Thromb Res; 1995 Oct; 80(2):161-8. PubMed ID: 8588193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of heparin in uremic patients during hemodialysis].
    Cullmann W; Glöckner WM; Müller N
    Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.